Abstract: The present invention relates generally to viral variants exhibiting reduced sensitivity to particular agents and/or reduced interactivity with immunological reagents. More particularly the present invention is directed to hepatitis B variants exhibiting complete or partial resistance to nucleoside analogues and/or reduced interactivity with antibodies to viral surface components. The present invention further contemplates assays for detecting such viral variants which assays are useful in monitoring anti-viral therapeutic regimes.
Type:
Application
Filed:
October 1, 2002
Publication date:
July 3, 2003
Applicant:
Western Health Care Network
Inventors:
Stephen A. Locarnini, Angeline I. Bartholomeusz, Thein T. Aye, Robert A. de Man
Abstract: The present invention relates generally to viral variants exhibiting reduced sensitivity to particular agents and/or reduced interactivity with immunological reagents. More particularly, the present invention is directed to hepatitis B variants exhibiting complete or partial resistance to nucleoside analogues and/or reduced interactivity with antibodies to viral surface components. The present invention further contemplates assays for detecting such viral variants which assays are useful in monitoring anti-viral therapeutic regimes.
Type:
Grant
Filed:
May 6, 1999
Date of Patent:
April 29, 2003
Assignee:
Western Health Care Network
Inventors:
Stephen A Locarnini, Angeline I. Bartholomeusz, Thein T. Aye, Robert A. de Man